Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.

Recs

0
Player Avatar pchop123 (79.52) Submitted: 4/24/2013 9:41:27 AM : Outperform Start Price: $8.75 SCMP Score: -5.25

UP, UP & Away

Featured Broker Partners


Advertisement